The risk of arterial thromboembolic events with chemotherapy appears to be increased with the addition of bevacizumab [Avastin]

By  

Inpharma, Vol. 1, Iss. 1492, 2005-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Safety of IVF under anticoagulant therapy in patients at risk for thrombo-embolic events

By Yinon Yoav   Pauzner Rachel   Dulitzky Mordechai   Elizur Shai E   Dor Jehoshua   Shulman Adrian  

Reproductive BioMedicine Online, Vol. 12, Iss. 3, 2006-03 ,pp. : 354-358

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Thromboembolic events a risk in off-label use of rFVIIa

By  

Reactions Weekly, Vol. 1, Iss. 1327, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Balancing the risk of chronic gastrointestinal bleeding and thromboembolic events in a patient with a metallic aortic valve

By  

Clinical Medicine, Vol. 8, Iss. 4, 2008-08 ,pp. : 461-462

Royal College Of Physicians

Access to resources Recommend Favorite

Do Some Inhibitors of COX-2 Increase the Risk of Thromboembolic Events?: Linking Pharmacology with Pharmacoepidemiology

By Clark D.W.J.   Layton D.   Shakir S.A.W.  

Drug Safety, Vol. 27, Iss. 7, 2004-01 ,pp. : 427-456

Adis International

Access to resources Recommend Favorite